Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China flag China · Delayed Price · Currency is CNY
51.40
-1.39 (-2.63%)
Sep 1, 2026, 3:04 PM CST

SHE:300347 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
7,1506,7136,4747,2897,0025,187
Other Revenue
140.09119.47129.0494.9383.9326.17
7,2906,8336,6037,3847,0855,214
Revenue Growth
12.23%3.48%-10.58%4.21%35.91%63.32%
Cost of Revenue
5,3744,9604,3594,5394,2772,943
Gross Profit
1,9161,8732,2442,8452,8082,271
Selling, General & Admin
960.35960.56944.45837.52780.02676.88
Research & Development
270257.64238.39261.56234.62211.83
Other Operating Expenses
51.6531.7122.219.157.1712.5
Operating Expenses
1,2691,2651,2351,1551,046926.93
Operating Income
647.11608.471,0091,6901,7631,344
Interest Expense
-68.97-90.56-141.24-119.9-83.18-24.91
Interest & Investment Income
215448.94256.86568.02330.09568.16
Currency Exchange Gain (Loss)
-11.71-16.9518.022.6120.13-11.83
Other Non Operating Income (Expenses)
-11.43-9.26-6.59-3.32-6.88-1.48
EBT Excluding Unusual Items
769.99940.641,1372,1382,0231,874
Impairment of Goodwill
-20.28-20.28-5-29.16--
Gain (Loss) on Sale of Investments
-313.8642.26-501.69352.77535.861,815
Gain (Loss) on Sale of Assets
-15.063.653.56-0.19-0.09-0.53
Asset Writedown
-1.66-0.22---0.45-
Other Unusual Items
61.1737.1631.0527.2427.1-3.96
Pretax Income
480.311,003664.462,4892,5853,685
Income Tax Expense
223.55198.16216.63338.61313.65292.86
Earnings From Continuing Operations
256.76805.06447.832,1502,2723,392
Minority Interest in Earnings
-165.3682.83-42.69-125.08-265.17-517.54
Net Income
91.39887.89405.142,0252,0072,874
Net Income to Common
91.39887.89405.142,0252,0072,874
Net Income Growth
-69.08%119.15%-79.99%0.91%-30.19%64.26%
Shares Outstanding (Basic)
860856863865865868
Shares Outstanding (Diluted)
860856863865866871
Shares Change
0.43%-0.83%-0.22%-0.07%-0.62%9.01%
EPS (Basic)
0.111.040.472.342.323.31
EPS (Diluted)
0.111.040.472.342.323.30
EPS Growth
-69.22%120.99%-79.94%0.86%-29.70%50.69%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
915.61903.72740.45836.68908.91,055
Free Cash Flow Per Share
1.061.060.860.971.051.21
Dividend Per Share
0.1260.1260.3000.5680.5500.500
Dividend Growth
-58.00%-58.00%-47.18%3.27%10.00%66.67%
Gross Margin
26.28%27.41%33.99%38.53%39.64%43.55%
Operating Margin
8.88%8.91%15.29%22.89%24.88%25.77%
Profit Margin
1.25%13.00%6.14%27.42%28.32%55.13%
Free Cash Flow Margin
12.56%13.23%11.21%11.33%12.83%20.24%
EBITDA
865.87820.31,2151,8761,9211,458
EBITDA Margin
11.88%12.01%18.40%25.40%27.12%27.97%
D&A For EBITDA
218.76211.84205.22185.06158.69114.71
EBIT
647.11608.471,0091,6901,7631,344
EBIT Margin
8.88%8.91%15.29%22.89%24.88%25.77%
Effective Tax Rate
46.54%19.75%32.60%13.61%12.13%7.95%
Revenue as Reported
7,2906,8336,6037,3847,0855,214
Advertising Expenses
-13.0514.119.9719.2414.45